相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phenotypic heterogeneity in persisters: a novel 'hunker' theory of persistence
J. Urbaniec et al.
FEMS MICROBIOLOGY REVIEWS (2022)
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study
J. Surey et al.
BMC INFECTIOUS DISEASES (2021)
Behcet's disease with latent Mycobacterium tuberculosis infection
Yan Shen et al.
OPEN MEDICINE (2021)
Quantifying the rates of late reactivation tuberculosis: a systematic review
Katie D. Dale et al.
LANCET INFECTIOUS DISEASES (2021)
Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon- Gamma Release Assay Cohort
Hyung Woo Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Small RNA Mcr11 requires the transcription factor AbmR for stable expression and regulates genes involved in the central metabolism of Mycobacterium tuberculosis
Roxie C. Girardin et al.
MOLECULAR MICROBIOLOGY (2020)
Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
Mariateresa Coppola et al.
FRONTIERS IN IMMUNOLOGY (2020)
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
Adam Penn-Nicholson et al.
SCIENTIFIC REPORTS (2020)
Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species
Abhirupa Ghosh et al.
Scientific Reports (2020)
Intricate Genetic Programs Controlling Dormancy in Mycobacterium tuberculosis
Eliza J. R. Peterson et al.
CELL REPORTS (2020)
A multilayered repair system protects the mycobacterial chromosome from endogenous and antibiotic-induced oxidative damage
Pierre Dupuy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosis
Timothy R. Sterling et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Mycobacterium tuberculosis progresses through two phases of latent infection in humans
Roberto Colangeli et al.
NATURE COMMUNICATIONS (2020)
Diagnosis for Latent Tuberculosis Infection: New Alternatives
Claudia Carranza et al.
FRONTIERS IN IMMUNOLOGY (2020)
Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds
Andre Campanico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mycobacterium tuberculosis Cells Surviving in the Continued Presence of Bactericidal Concentrations of Rifampicin in vitro Develop Negatively Charged Thickened Capsular Outer Layer That Restricts Permeability to the Antibiotic
Jees Sebastian et al.
FRONTIERS IN MICROBIOLOGY (2020)
A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent Tuberculosis
Ushashi Banerjee et al.
FRONTIERS IN CHEMISTRY (2020)
Approaches to treating tuberculosis by encapsulating metal ions and anti-mycobacterial drugs utilizing nano- and microparticle technologies
Khaled H. Alzahabi et al.
EMERGING TOPICS IN LIFE SCIENCES (2020)
The relevance of persisters in tuberculosis drug discovery
Soma Mandal et al.
MICROBIOLOGY-SGM (2019)
Errors in translational decoding: tRNA wobbling or misincorporation?
Xumin Ou et al.
PLOS GENETICS (2019)
Latent tuberculosis infection in patients with rheumatic diseases
Camila Anton et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2019)
Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From Ghana
Ernest Adankwah et al.
FRONTIERS IN IMMUNOLOGY (2019)
Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis
Marie Nancy Seraphin et al.
BMC PUBLIC HEALTH (2019)
Bacterial persistence: Fundamentals and clinical importance
Sung-Hee Jung et al.
JOURNAL OF MICROBIOLOGY (2019)
Is Mycobacterium tuberculosis infection life long?
Marcel A. Behr et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Impact of the host environment on the antitubercular action of pyrazinamide
Elise A. Lamont et al.
EBIOMEDICINE (2019)
Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection
Jonathan Mayito et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection
Paul K. Drain et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis
Julie G. Burel et al.
JOURNAL OF IMMUNOLOGY (2018)
Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan
Jin Takasaki et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2018)
High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques
Marcelo J. Kuroda et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination
Mariateresa Coppola et al.
SEMINARS IN IMMUNOLOGY (2018)
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan
Hsin-Yun Sun et al.
TUBERCULOSIS (2018)
A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection
Akul Singhania et al.
NATURE COMMUNICATIONS (2018)
Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria
Alexandra Sakatos et al.
SCIENCE ADVANCES (2018)
Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy
Sajith Raghunandanan et al.
JOURNAL OF ANTIBIOTICS (2018)
AbmR (Rv1265) is a novel transcription factor of Mycobacterium tuberculosis that regulates host cell association and expression of the non-coding small RNA Mcr11
Roxie C. Girardin et al.
MOLECULAR MICROBIOLOGY (2018)
Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru
Moises A. Huaman et al.
PLOS ONE (2018)
Persister Cells - a Plausible Outcome of Neutral Coevolutionary Drift
T. M. Khlebodarova et al.
SCIENTIFIC REPORTS (2018)
Revisiting the timetable of tuberculosis
Marcel A. Behr et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro
Jees Sebastian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication
Justin T. Denholm et al.
INTERNAL MEDICINE JOURNAL (2017)
Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity
E. Hesper Rego et al.
NATURE (2017)
Persistent bacterial infections and persister cells
Robert A. Fisher et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression
Mariateresa Coppola et al.
TUBERCULOSIS (2017)
Benzoylphenyl thiocyanates are new, effective inhibitors of the mycobacterial resuscitation promoting factor B protein
Galina R. Demina et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
The Numerical Predominance and Large Transcriptome Differences of Neutrophils in Peripheral Blood Together Inevitably Account for a Reported Pulmonary Tuberculosis Signature
Kang Wu et al.
INTERNATIONAL JOURNAL OF GENOMICS (2017)
Mycobacterial Dormancy Systems and Host Responses in Tuberculosis
Vidyullatha Peddireddy et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
Tan N. Doan et al.
PLOS ONE (2017)
Delayed effects of transcriptional responses in Mycobacterium tuberculosis exposed to nitric oxide suggest other mechanisms involved in survival
Teresa Cortes et al.
SCIENTIFIC REPORTS (2017)
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection A Randomized Trial
Robert Belknap et al.
ANNALS OF INTERNAL MEDICINE (2017)
Heterogeneity in tuberculosis
Anthony M. Cadena et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis
Peter Auguste et al.
BMC INFECTIOUS DISEASES (2017)
Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
T. Schon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Diagnostics for latent TB infection: incremental, not transformative progress
Madhukar Pai et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country
Wei-Cheng Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Daniel E. Zak et al.
LANCET (2016)
Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F] fluoro-D-glucose positron emission and computed tomography
Hanif Esmail et al.
NATURE MEDICINE (2016)
CD8+ T cells in human autoimmune arthritis: the unusual suspects
Alessandra Petrelli et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis
Robert L. Hunter
TUBERCULOSIS (2016)
tRNA-mediated codon-biased translation in mycobacterial hypoxic persistence
Yok Hian Chionh et al.
NATURE COMMUNICATIONS (2016)
Comprehensive Transcriptome Meta-analysis to Characterize Host Immune Responses in Helminth Infections
Guangyan Zhou et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9, EPHA4, and NPC2 mRNA Expression in Peripheral Blood
Leonardo S. de Araujo et al.
FRONTIERS IN MICROBIOLOGY (2016)
Updates on the risk factors for latent tuberculosis reactivation and their managements
Jing-Wen Ai et al.
EMERGING MICROBES & INFECTIONS (2016)
The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity
Hong-Wei Su et al.
NATURE MICROBIOLOGY (2016)
Role of alpha-crystallin, early-secreted antigenic target 6-kDa protein and culture filtrate protein 10 as novel diagnostic markers in osteoarticular tuberculosis
Nazia Rizvi et al.
JOURNAL OF ORTHOPAEDIC TRANSLATION (2016)
New Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles
Mariateresa Coppola et al.
SCIENTIFIC REPORTS (2016)
L-form transformation phenomenon in Mycobacterium tuberculosis associated with drug tolerance to ethambutol
Georgi Slavchev et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2016)
Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA
Dmitriy V. Ignatov et al.
BMC GENOMICS (2015)
Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis
Giovanni Piccaro et al.
JOURNAL OF ANTIBIOTICS (2015)
Profiling the Proteome of Mycobacterium tuberculosis during Dormancy and Reactivation
Vipin Gopinath et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
A Systematic Review on TST and IGRA Tests Used for Diagnosis of LTBI in Immigrants
Jonathon R. Campbell et al.
MOLECULAR DIAGNOSIS & THERAPY (2015)
Biomarkers of An Autoimmune Skin Disease-Psoriasis
Shan Jiang et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2015)
Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update
S. Sollai et al.
BMC INFECTIOUS DISEASES (2014)
Diagnosis of latent tuberculosis infection among immunodeficient individuals: review of concordance between interferon-gamma release assays and the tuberculin skin test
S. Mamishi et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2014)
Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids
C. J. Cambier et al.
NATURE (2014)
Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans
Roberto Colangeli et al.
PLOS ONE (2014)
Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance
Babak Javid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
Ma del Mar Serra-Vidal et al.
FRONTIERS IN MICROBIOLOGY (2014)
The Normalcy of Dormancy: Common Themes in Microbial Quiescence
Emily S. C. Rittershaus et al.
CELL HOST & MICROBE (2013)
The lpqS knockout mutant of Mycobacterium tuberculosis is attenuated in Macrophages
Suba Sakthi et al.
MICROBIOLOGICAL RESEARCH (2013)
Correction: Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
Chloe I. Bloom et al.
PLoS One (2013)
Genome-wide Mapping of Transcriptional Start Sites Defines an Extensive Leaderless Transcriptome in Mycobacterium tuberculosis
Teresa Cortes et al.
CELL REPORTS (2013)
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting
Novel N. Chegou et al.
BMC INFECTIOUS DISEASES (2012)
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
David M. Tobin et al.
CELL (2012)
Mycobacterium tuberculosis: Immune evasion, latency and reactivation
Antima Gupta et al.
IMMUNOBIOLOGY (2012)
Mycobacterium tuberculosis Growth following Aerobic Expression of the DosR Regulon
Kyle Minch et al.
PLOS ONE (2012)
Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility
Bree B. Aldridge et al.
SCIENCE (2012)
A microfluidic system for long-term time-lapse microscopy studies of mycobacteria
Solmaz A. Golchin et al.
TUBERCULOSIS (2012)
Filterable forms and L-forms of Mycobacterium bovis BCG Impact for live vaccine features
Nadya Markova et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens?
Melanie J. Harriff et al.
FRONTIERS IN IMMUNOLOGY (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Human Lung Immunity against Mycobacterium tuberculosis Insights into Pathogenesis and Protection
Stephan Schwander et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Identification of Human T-Cell Responses to Mycobacterium tuberculosis Resuscitation-Promoting Factors in Long-Term Latently Infected Individuals
Susanna Commandeur et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Heterogeneous bacterial persisters and engineering approaches to eliminate them
Kyle R. Allison et al.
CURRENT OPINION IN MICROBIOLOGY (2011)
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection
Christopher B. Ford et al.
NATURE GENETICS (2011)
Novel Biomarkers Distinguishing Active Tuberculosis from Latent Infection Identified by Gene Expression Profile of Peripheral Blood Mononuclear Cells
Chanyi Lu et al.
PLOS ONE (2011)
Novel M tuberculosis Antigen-Specific T-Cells Are Early Markers of Infection and Disease Progression
Davinder P. S. Dosanjh et al.
PLOS ONE (2011)
Pathology of post primary tuberculosis of the lung: An illustrated critical review
Robert L. Hunter
TUBERCULOSIS (2011)
Letting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis?
Michael C. Chao et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country
Anne M. Dyrhol-Riise et al.
BMC INFECTIOUS DISEASES (2010)
Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls
Jiazhen Chen et al.
BMC INFECTIOUS DISEASES (2010)
A 100 year update on diagnosis of tuberculosis infection
Ajit Lalvani et al.
BRITISH MEDICAL BULLETIN (2010)
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
D. Goletti et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
C. B. E. Chee et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak
Seung Heon Lee et al.
RESPIRATORY MEDICINE (2010)
4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta-analysis and Cost-Effectiveness Study That Focuses on Compliance and Liver Toxicity
Panayiotis D. Ziakas et al.
CLINICAL INFECTIOUS DISEASES (2009)
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
U. Mack et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Clifton E. Barry et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Identification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis Infection
Sebastian D. Schuck et al.
PLOS ONE (2009)
Finding of the Low Molecular Weight Inhibitors of Resuscitation Promoting Factor Enzymatic and Resuscitation Activity
Galina R. Demina et al.
PLOS ONE (2009)
DevR-mediated adaptive response in Mycobacterium tuberculosis H37Ra: Links to asparagine metabolism
Vandana Malhotra et al.
TUBERCULOSIS (2009)
Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
Alma Tostmann et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
The Enduring Hypoxic Response of Mycobacterium tuberculosis
Tige R. Rustad et al.
PLOS ONE (2008)
Exhibition of persistent and drug-tolerant L-form habit of Mycobacterium tuberculosis during infection in rats
Nadya Markova et al.
CENTRAL EUROPEAN JOURNAL OF BIOLOGY (2008)
Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis
Petros C. Karakousis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice
Sergey Biketov et al.
BMC INFECTIOUS DISEASES (2007)
Expression of mycobacterial cell division protein, FtsZ, and dormancy proteins, DevR and Acr, within lung granulomas throughout guinea pig infection
Deepak Sharma et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Opinion - Non-inherited antibiotic resistance
Bruce R. Levin et al.
NATURE REVIEWS MICROBIOLOGY (2006)
High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis
AB Younossian et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice
PC Karakousis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Persistent and dormant tubercle bacilli and latent tuberculosis
Y Zhang
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Transcriptional adaptation of Mycobacterium tuberculosis within macrophages:: Insights into the phagosomal environment
D Schnappinger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis
HD Park et al.
MOLECULAR MICROBIOLOGY (2003)